DCGO Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -5.33%, SMA50 -14.41%, SMA200 -42.36%). The stock’s 14-day RSI is 39.91 (weak momentum), while the ATR of 0.06 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -83.58% below its high and over 7.78% above its low. Average 10-day trading volume of 1.33 million shares is significantly above the 3-month average of 882.96 thousand, indicating heightened recent market interest.

DocGo Inc. has 98.78 million shares outstanding. The public float is 95.97 million shares, elevated short interest at 2.40% of float. This equals 2.31 million shares. The short ratio is 1.82 days. Institutional investors hold 46.42% of the float. Insiders own 3.07%. Bienstock Lee holds 1.97 million shares, Oberholzer Adriaan Stephanus has 1.11 million shares and ROSENBERG NORMAN has 871.27 thousand shares.

The latest quarter delivered EPS of -$0.10. The next quarter is forecast at -$0.14. Next year's EPS is expected at $181.94. Analyst sentiment is neutral. Analyst rating data shows there are 1 Strong Buy ratings, 2 Buy ratings, 4 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $3.00 to $1.00. The high target offers 597.67% upside. The low target suggests 132.56% downside. The mean target is $1.94. This offers 351.16% upside. DocGo Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 17, 2026, missed forecasts by 2.56%. The prior quarter beat by 650.0%. Over the last six quarters, Apple has recorded several small beats. These include 800.0% in May 08, 2025.

DocGo Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.71. This means the shares are trading below this model’s fair value.

The stock is currently mid-range between its 52-week high and low $0.40 and $1.73. With a market capitalization of about $42.92 million, DocGo Inc. is classified as a micro-cap and shows market-like volatility (beta ~0.99). Key stats such as the average daily volume over the past year has been around 895.15 thousand shares, volume is running light vs its 52-week average. Headquartered in New York City, NY, DocGo Inc. operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Lee Bienstock, the company employs approximately 3,568 people and listed since December 17, 2020. DocGo Inc. is a company dedicated to providing mobile healthcare solutions and medical transportation for a wide array of healthcare organizations in both the United States and the United Kingdom.

DocGo Inc. trades at a P/E ratio of -0.22, slightly below the S&P 500 average, with a price-to-sales ratio of 0.15 and a price-to-book ratio of 0.36 suggesting the stock is closer to book value. The P/FCF stands at -1.59, also above market averages.

DocGo Inc. (NASDAQ:DCGO) shares are flat -7.47% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows DocGo Inc. trading at a premium to the broader market with a P/E of -0.22. Analyst sentiment is mixed, with the majority of ratings in Hold territory and a mean price target of $8.56, suggesting 1870.08% upside. Our AI forecast model points to short-term weakness (-1.04% over two weeks), a medium-term fall (-70.08% over three months), and a longer-term gain (21.98% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that DocGo Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.04%, with price expected at $0.43 by September 03, 2026, within a range of $0.38 to $0.49 3-Month Outlook: Projected fall of -70.08%, reaching $0.13 by November 18, 2026, with a range of $0.08 to $0.18. 1-Year Outlook: Projected gain of 21.98%, with price at $0.53 by August 20, 2027, within a range of $0.00 to $0.00.